Literature DB >> 23619444

A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population.

Tejas K Patel1, Manish J Barvaliya, Dineshchandra Sharma, Chandrabhanu Tripathi.   

Abstract

BACKGROUND: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare severe cutaneous drug reactions. No large scale epidemiological data are available for this disorder in India. AIMS: To carry out a systematic review of the published evidence of the drug-induced SJS and TEN in Indian population.
METHODS: Publications from 1995 to 2011 describing SJS and TEN in Indian population were searched in PubMed, MEDLINE, EMBASE and UK PUBMED Central electronic databases. Data were collected for the causative drugs and other clinical characteristics of SJS and TEN from the selected studies.
RESULTS: From 225 references, 10 references were included as per selection criteria. The major causative drugs were antimicrobials (37.27%), anti-epileptics (35.73%) and non-steroidal anti-inflammatory drugs (15.93%). Carbamazepine (18.25%), phenytoin (13.37%), fluoroquinolones (8.48%) and paracetamol (6.17%) were most commonly implicated drugs. Regional differences were observed for fluoroquinolones, sulfa drugs and carbamazepine. Total 62.96% of patients showed systemic complications. Most common complications were ocular (40.29%) and septicemia (17.65%). Higher mortality was observed for TEN as compared to SJS (odd ratio-7.19; 95% confidence interval (CI) 1.62-31.92; p = 0.0023). Observed mortality is higher than expected as per SCORTEN score 3. Duration of hospital stay was significantly higher in TEN (20.6 days; 95% CI 14.4-26.8) as compared to SJS (9.7 days; 95% CI 5.8-13.6; p = 0.020). Cost of management was significantly higher in TEN (Rs. 7910; 95% CI 5672-10147; p < 0.0001) as compared to SJS (Rs 2460; 95% CI 1762-3158). No statistical data were described for steroid use in the studies included.
CONCLUSION: Carbamazepine, phenytoin, fluoroquinolones and paracetamol were the major causative drugs. TEN is showing higher mortality, morbidity and economic burden than SJS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23619444     DOI: 10.4103/0378-6323.110749

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  23 in total

1.  Toxic epidermal necrolysis associated with radiotherapy and phenytoin in a patient with non-Hodking's lymphoma: A case report.

Authors:  Fatma Keklik; Melda Cömert Özkan; Gizem Kocabaş Yenipazar; Banu Yaman; Güray Saydam; Fahri Şahin
Journal:  Rep Pract Oncol Radiother       Date:  2015-10-17

2.  Stevens-Johnson syndrome in a patient with rheumatoid arthritis during long-term etanercept therapy.

Authors:  Agnieszka Owczarczyk-Saczonek; Natalia Zdanowska; Aleksandra Znajewska-Pander; Waldemar Placek
Journal:  J Dermatol Case Rep       Date:  2016-03-31

3.  Is acetaminophen associated with a risk of Stevens-Johnson syndrome and toxic epidermal necrolysis? Analysis of the French Pharmacovigilance Database.

Authors:  Bénédicte Lebrun-Vignes; Claire Guy; Marie-Josèphe Jean-Pastor; Valérie Gras-Champel; Marie Zenut
Journal:  Br J Clin Pharmacol       Date:  2017-11-10       Impact factor: 4.335

Review 4.  Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Authors:  Jonathan Grant Peter; Rannakoe Lehloenya; Sipho Dlamini; Kimberly Risma; Katie D White; Katherine C Konvinse; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017 May - Jun

Review 5.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

Review 6.  Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.

Authors:  Audrey Jacobsen; Bayanne Olabi; Annie Langley; Jennifer Beecker; Eric Mutter; Amanda Shelley; Brandon Worley; Timothy Ramsay; Arturo Saavedra; Roses Parker; Fiona Stewart; Jordi Pardo Pardo
Journal:  Cochrane Database Syst Rev       Date:  2022-03-11

7.  Cutaneous adverse drug reactions in Indian population: A systematic review.

Authors:  Tejas K Patel; Sejal H Thakkar; Dc Sharma
Journal:  Indian Dermatol Online J       Date:  2014-12

8.  Dermoscopic Aspects of Cutaneous Adverse Drug Reactions.

Authors:  Gabriela Rossi; André da Silva Cartell; Renato Marchiori Bakos
Journal:  Dermatol Pract Concept       Date:  2021-01-29

9.  Compensation for occupational skin diseases.

Authors:  Han-Soo Song; Hyun-chul Ryou
Journal:  J Korean Med Sci       Date:  2014-06-13       Impact factor: 2.153

10.  Paracetamol induced Steven-Johnson syndrome: A rare case report.

Authors:  Rajan Rajput; Shitalkumar Sagari; Astha Durgavanshi; Alpana Kanwar
Journal:  Contemp Clin Dent       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.